Predicting distant metastases in operable breast cancer patients

Area of Science:

• Oncology
• Surgical Oncology
• Pathology

Background:

• Mastectomy and axillary node dissection are standard breast cancer treatments.
• Identifying reliable prognostic factors for distant metastases is crucial for patient management.

Purpose of the Study:

• To analyze stable risk factors for distant metastases after mastectomy and axillary node dissection.
• To develop a prognostic stratification for operable breast cancer patients.

Main Methods:

• A review of 1022 women undergoing mastectomy and axillary node dissection.
• Utilized Cox model-based prognosis studies at six distinct stages from diagnosis to adjuvant treatment completion.
• Evaluated tumor size, nuclear pleomorphism, mitotic index, nodal status, clinical node status, age, vascular tumor emboli, estrogen, progesterone, histologic grade, and clinical stage.

Main Results:

• Tumor size, nuclear pleomorphism, mitotic index, and axillary nodal status were identified as stable independent risk factors for metastasis-free survival (MFS).
• Clinical node status, age, and vascular tumor emboli showed stage-dependent significance.
• Estrogen, progesterone, histologic grade, and clinical stage were not independent predictors of MFS at any stage.
• A stratification based on four stable risk factors was defined, classifying 51-64% of patients based on available clinical and pathological data.

Conclusions:

• Accurate prognosis of operable breast cancer patients before axillary node dissection is challenging due to insufficient predictive power of current clinical information alone.
• Subsets of patients with stable prognoses exist, remaining consistently in the same risk group throughout treatment stages.